Professor | 田君 | 数字化转型顾问

Upload Avatar (500 x 500)

Name

田君

Contact Information

tianj@sustech.edu.cn

Language ability

英语, 汉语

Province

广东省

University/Lab Affiliation and Title	南方科技大学
Faculty	Medical School
Academic Background & Achievements	2009-2013 学士: 南开大学 2013-2018 博士: 加拿大麦吉尔大学获得麦吉尔大学优秀博士毕业生奖
Work Experience	2023.08-至今南方科技大学医学院，助理教授 2019-2023 美国哈佛医学院麻省总医院，博士后 2018-2019 加拿大麦吉尔大学健康中心，博士后
Awards	2018: 加拿大麦吉尔大学优秀博士毕业生奖 2017: 加拿大麦吉尔大学医学院优秀生产力奖

University/Lab Affiliation and Title

南方科技大学

Faculty

Medical School

Academic Background & Achievements

Work Experience

Awards

Areas of Focus	癌症的靶向和免疫治疗药物耐药性机制肿瘤类器官模型的建立和药物测试
Publications	Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial, 田君等, 2023 Targeting TBK1 to overcome resistance to cancer immunotherapy, 田君等, 2023 Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition, 田君等, 2021 Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis, 田君等, 2021 Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells, 田君等, 2018 KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer, 田君等, 2018 Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer, 田君等, 2017 Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function, 田君等, 2017 The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma, 田君等, 2015 Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes, 田君等, 2014

Areas of Focus

癌症的靶向和免疫治疗
药物耐药性机制
肿瘤类器官模型的建立和药物测试

Publications

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial, 田君等, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy, 田君等, 2023
Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition, 田君等, 2021
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis, 田君等, 2021
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells, 田君等, 2018
KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer, 田君等, 2018
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer, 田君等, 2017
Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function, 田君等, 2017
The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma, 田君等, 2015
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes, 田君等, 2014

癌症靶向治疗免疫治疗药物耐药机制肿瘤器官模型药物测试肿瘤学治疗策略

刘泉 - 南方科技大学

Area of Focus
肿瘤 | 免疫学 | 免疫治疗 | 神经免疫代谢 | 细胞因子 | Il-33 | 神经递质 | Cgrp | Nmu | Ne | Ilc | Treg | 移植 | 免疫生物学

谭鹏 - 南方科技大学

Area of Focus
免疫 | 病毒 | 肿瘤 | 癌症 | 神经学 | 胃肠病学 | 免疫治疗 | 分子生物学 | 细胞生物学 | 遗传学

张政 - 南方科技大学

Area of Focus
免疫致病机制 | 病原体 | 感染 | 免疫治疗 | 治疗 | 策略 | 疾病 | 机制 | 研究 | 临床

View All

Personal Information